NO20072879L - Metoder og forbindelser for fremstilling av substituterte naftylindolderivater - Google Patents

Metoder og forbindelser for fremstilling av substituterte naftylindolderivater

Info

Publication number
NO20072879L
NO20072879L NO20072879A NO20072879A NO20072879L NO 20072879 L NO20072879 L NO 20072879L NO 20072879 A NO20072879 A NO 20072879A NO 20072879 A NO20072879 A NO 20072879A NO 20072879 L NO20072879 L NO 20072879L
Authority
NO
Norway
Prior art keywords
substituted
preparation
compounds
methods
derivatives
Prior art date
Application number
NO20072879A
Other languages
English (en)
Inventor
Jean Louise Helom
John R Potoski
Vladimir A Dragan
Wayne G Mcmahon
Xinxu Shi
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20072879L publication Critical patent/NO20072879L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer prosesser for fremstilling av substituerte naftylindol derivater som kan anvendes som inhibitorer av plasminogen aktivator inhibitor-1 (PAI-1). I visse utførelsesformer ifølge oppfinnelsen, involverer prosessene reaksjoner som omfatter én eller flere av en Oppenauer oksidasjon, en Fischer indol syntese, en metyleter spaltning eller kobling av et substituert metyltetrazol med et substituert naftol. ?? ?? ?? ?? 40
NO20072879A 2005-01-27 2007-06-06 Metoder og forbindelser for fremstilling av substituterte naftylindolderivater NO20072879L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64761805P 2005-01-27 2005-01-27
PCT/US2006/002996 WO2006081455A1 (en) 2005-01-27 2006-01-25 Processes and compounds for the preparation of substituted naphthylindole derivatives

Publications (1)

Publication Number Publication Date
NO20072879L true NO20072879L (no) 2007-06-26

Family

ID=36570379

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072879A NO20072879L (no) 2005-01-27 2007-06-06 Metoder og forbindelser for fremstilling av substituterte naftylindolderivater

Country Status (21)

Country Link
US (2) US7323483B2 (no)
EP (1) EP1856104A1 (no)
JP (1) JP2008528618A (no)
KR (1) KR20070103744A (no)
CN (1) CN101111491A (no)
AR (1) AR053437A1 (no)
AU (1) AU2006208021A1 (no)
BR (1) BRPI0606871A2 (no)
CA (1) CA2595376A1 (no)
CR (1) CR9215A (no)
GT (1) GT200600032A (no)
HN (1) HN2006003347A (no)
IL (1) IL183712A0 (no)
MX (1) MX2007008952A (no)
NI (1) NI200700188A (no)
NO (1) NO20072879L (no)
PE (1) PE20061200A1 (no)
RU (1) RU2007121255A (no)
TW (1) TW200637850A (no)
WO (1) WO2006081455A1 (no)
ZA (1) ZA200706203B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007092207A1 (en) * 2006-02-03 2007-08-16 Wyeth Compositions for the delivery of substituted naphthyl indole derivatives and methods of their use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903206A1 (en) 1989-09-07 1991-03-13 Abbott Lab Indole-, benzofuran-, and benzothiophene-containing¹lipoxygenase-inhibiting compounds
US5151435A (en) * 1991-04-08 1992-09-29 Merck & Co., Inc. Angiotensin ii antagonists incorporating an indole or dihydroindole
IL101785A0 (en) 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL109568A0 (en) 1993-05-19 1994-08-26 Fujisawa Pharmaceutical Co Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
CA2134192A1 (en) 1993-11-12 1995-05-13 Michael L. Denney 5, 6-bicyclic glycoprotein iib/iiia antagonists
US5552412A (en) 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
IL120724A0 (en) 1995-09-01 1997-08-14 Lilly Co Eli Indolyl neuropeptide Y receptor antagonists
JP2000516958A (ja) 1996-08-26 2000-12-19 ジェネティックス・インスチチュート・インコーポレーテッド ホスホリパーゼ酵素の阻害剤
US6703527B2 (en) * 2001-05-24 2004-03-09 Nikken Chemicals Co., Ltd. Method for oxidation of allyl alcohol
TWI224101B (en) * 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
TW591020B (en) 2001-06-20 2004-06-11 Wyeth Corp 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)

Also Published As

Publication number Publication date
AR053437A1 (es) 2007-05-09
NI200700188A (es) 2008-05-09
RU2007121255A (ru) 2009-03-10
TW200637850A (en) 2006-11-01
US20080071091A1 (en) 2008-03-20
KR20070103744A (ko) 2007-10-24
MX2007008952A (es) 2007-09-18
GT200600032A (es) 2006-11-14
CR9215A (es) 2007-11-23
CA2595376A1 (en) 2006-08-03
WO2006081455A1 (en) 2006-08-03
IL183712A0 (en) 2007-09-20
AU2006208021A1 (en) 2006-08-03
HN2006003347A (es) 2011-03-30
CN101111491A (zh) 2008-01-23
EP1856104A1 (en) 2007-11-21
BRPI0606871A2 (pt) 2009-07-21
PE20061200A1 (es) 2006-12-19
JP2008528618A (ja) 2008-07-31
US7323483B2 (en) 2008-01-29
US20060183917A1 (en) 2006-08-17
ZA200706203B (en) 2009-12-30

Similar Documents

Publication Publication Date Title
CY1110337T1 (el) Παρασκευη πρεγκαμπαλινης και σχετικων ενωσεων
CR11618A (es) Inhibidores macrocíclicos de serina proteasa
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
BRPI0414792A (pt) derivados de ácido 4-(1h-indol-3-il-metilidenoaminóxi-propóxi)-benzóico e compostos relacionados como inibidores de pai-1 para o tratamento de enfraquecimento do sistema fibrinolìtico e de trombose
MY145080A (en) Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
NO20081636L (no) FAP - inhibitorer
NO20061072L (no) Doseringsformer som tilveiebringer kontrollert frigivning av kolesterylesteroverfonngsprotetntnhibttorer og umiddelbar frigivning av HMG-COA-reduktase-Inhibitor
NO20071309L (no) Fremgangsmate for ekspansjon
NO20083147L (no) Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
EA200970605A1 (ru) Ингибиторы mapk/erk-киназ
CY1113314T1 (el) (3-αρυλ-πιπεραζιν-1-υλ) παραγωγα της 6,7-διαλκοξυκιναζολινης, 6,7-διαλκοξυφθαλαζινης και 6,7-διαλκοξυϊσοκινολινης
NO20084320L (no) Antistoffer mot EGFL7 og fremgangsmater for anvendelse av disse
NO20081621L (no) Tetrahydrokinoliner, syntese og intermediater
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
NO20080468L (no) Diazepinokinoliner, synteser av disse samt intermediater
DE60316984D1 (de) Benzoylsulfonamide als antitumor-mittel
NO20050019L (no) Polytylenglykolaldehyd-derivater
NO20075140L (no) Fremgangsmater og preparater for modulering av vaskulaer integritet
SE0103710D0 (sv) Compounds
UA96277C2 (en) Benzimidazole derivatives
WO2006023866A3 (en) Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
GEP20074257B (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in the synthesis of perindopril
NO20064715L (no) Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application